Schedule 13D ownership disclosure
Obalon Therapeutics Inc
Security class unavailable · CUSIP: 67424L100
Event date: 2018-08-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 24.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-18-000545
- Form type
- SC 13D
- Filer
- DOMAIN PARTERS VII L P
- CIK
- CIK 1374150
- Filed
- Aug 31, 2018
- Reporting period
- Aug 23, 2018
- Description
- Schedule 13D beneficial ownership